Lymphoma Clinical Trials
Lymphoma Clinical Trials
TRIALS CURRENTLY OPEN
USON 16176
A Multicenter, Randomized, Double-blind Placebo-controlled Phase 3 Study of Bruton’s Tyrosine Kinas (BTK) Inhibitor, Ibrutinib, in Combination with Rituximb versus Placebo in Combination with Rituximab in Treatment Naïve Subjects with Follicular Lymphoma
USON 19062
A Phase 1B/3 Randomized, Double-blind, Active-controlled 3-Stage Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma (EZH-302)
USON 19084
Waldenstrom’s Lymphoma- Relapsed or Refractory using Zanubritinib
Also See STAR Trials – USOR #11282, #18013